Beclin 1, a mammalian autophagy protein that has been implicated in development, tumour suppression, neurodegeneration and cell death, exists in a complex with Vps34, the class III phosphatidylinositol-3-kinase (PI(3)K) that mediates multiple vesicle-trafficking processes including endocytosis and autophagy. However, the precise role of the Beclin 1-Vps34 complex in autophagy regulation remains to be elucidated. Combining mouse genetics and biochemistry, we have identified a large in vivo Beclin 1 complex containing the known proteins Vps34, p150/Vps15 and UVRAG, as well as two newly identified proteins, Atg14L (yeast Atg14-like) and Rubicon (RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein). Characterization of the new proteins revealed that Atg14L enhances Vps34 lipid kinase activity and upregulates autophagy, whereas Rubicon reduces Vps34 activity and downregulates autophagy. We show that Beclin 1 and Atg14L synergistically promote the formation of double-membraned organelles that are associated with Atg5 and Atg12, whereas forced expression of Rubicon results in aberrant late endosomal/ lysosomal structures and impaired autophagosome maturation. We hypothesize that by forming distinct protein complexes, Beclin 1 and its binding proteins orchestrate the precise function of the class III PI(3)K in regulating autophagy at multiple steps.
1
. Initially identified as a Bcl-2-binding protein 2 , Beclin 1 has been shown both in vitro and in vivo to participate in autophagy regulation and to have important roles in development 3 , tumorigenesis 1, [3] [4] [5] and neurodegeneration [6] [7] [8] . As with yeast Atg6, Beclin 1 forms a complex with Vps34/class III PI(3)K [9] [10] [11] . Saccharomyces cerevisiae has at least two Atg6/Vps34 protein complexes: one containing Atg14 and participating in autophagy, and the other containing Vps38 and functioning in non-autophagic pathways 10 . However, there is no concrete evidence for multiple Beclin 1-Vps34 complexes or multiple functions associated with Beclin 1-Vps34 in mammals 11 . To determine the mechanism by which the Beclin 1-Vps34 interaction regulates autophagy, we combined mouse genetics and biochemistry to identify Beclin 1-associated protein complexes in vivo. We genetically modified mice to functionally replace endogenous Beclin ;Becn1-EGFP/+), only the Beclin 1-EGFP fusion protein, but not endogenous Beclin 1 was detected by an anti-Beclin 1 antibody (Fig. 1a) . These mice were born at the expected Mendelian ratio ( Supplementary  Information, Fig. S1c ), survived postnatally and were phenotypically normal at the adult stage, suggesting a full 'rescue' of the embryonic lethality of Becn1 -/-mice by a functional Becn1-EGFP transgene. Using these 'rescued' mice, we isolated Beclin 1-EGFP protein complexes by affinity purification from liver, brain (Fig. 1b) and thymus (data not shown), and identified their components using mass-spectrometry ( Supplementary Information, Fig. S2 ). The rescued mice, but not the control mice, were associated with at least six readily detectable protein bands common to both liver and brain (Fig. 1b) . These bands include Beclin 1-EGFP (no. 5; molecular mass of about 90,000), three previously reported Beclin 1-binding proteins p150/Vps15 (no. 1; ref. 12) , Vps34 (no. 3; refs 9-11) and UVRAG (no. 4; ref. 13) , and two newly identified proteins (nos 2 and 6). The first of these two proteins (no. 6, ~60K, gi|27369860) contains 492 amino acids and has a conserved SMC (structural maintenance of chromosomes) motif or two coiled-coil domains (CCD; amino acids 75-95 and 148-178) near the amino terminus (Fig. 1c) . Interestingly, the sequence of this protein shows modest similarity to yeast Atg14 (overall 15% identity; Supplementary Information, Fig. S3a ). Thus, we named this protein Atg14L for yeast Atg14-like. The second protein (no. 2, ~124K, gi|45708948) contains 941 amino acids and has a conserved RUN domain (amino acids 49-190) near the amino terminus, a cysteine-rich domain (amino acids 837-890) near the carboxy terminus and a CCD (amino acids 488-508) in the central region (Fig. 1c) . Thus, we named this protein Rubicon for RUN domain, a cysteine-rich domain containing, Beclin 1-interacting protein. No sequence homology was observed between Rubicon and Vps38 or Atg14 (data not shown). Notably, the protein levels of affinity-purified Beclin 1-EGFP, p150/Vps15, Vps34 and UVRAG were comparable and reproducibly higher than those of Atg14L and Rubicon (Fig. 1b) , suggesting a stable 'core' Beclin 1-Vps34 complex consisting of Beclin 1, Vps34, p150 and UVRAG. Additionally, we did not detect the previously identified Beclin 1-associated proteins, such as nPIST +/-littermates (lanes 1 and 3), using an anti-GFP antibody. Proteins in the gel bands were extracted and identified by mass spectrometry as Vps15/p150 (band 1), Vps34/class III PI(3)K (band 3), UVRAG (band 4), Beclin 1-EGFP (band 5), Atg14L (band 6, asterisk, gi|27369860) and Rubicon (band 2, asterisk, gi|45708948). UVRAG levels varied with different affinity-purification conditions, suggesting an unstable association of UVRAG with the complex. (c) Schematic representations of the domain structures of Atg14L and Rubicon. Atg14L contains two coiled-coil domains (CCD1 and CCD2), which are also homologous with the SMC domain (structural maintenance of chromosomes). Rubicon contains an N-terminal RUN (for RPIP8, UNC-14 and NESCA) domain, a C-terminal Cys-rich domain and a central CCD domain. (d) Western blot analysis of Atg14L, Rubicon, Vps34 and Beclin 1 in gel filtration fractions from wild-type mouse liver extract showed co-elution of these proteins in fractions 38-45. Atg14L was also eluted in later fractions 51-56. The fractions for the peak elution of thyroglobulin (670K) and γ-globulin (158K) are indicated by arrows. Control siRNA-transfected NIH 3T3 cell lysate was loaded as a positive control (labelled as 1) for the migration position of the Atg14L protein on SDS-PAGE; Atg14L siRNA-transfected NIH 3T3 cell lysate was loaded as a negative control (labelled as 2). (e, f) Co-immunoprecipitation confirmed protein-protein interaction between Atg14L and Rubicon. HEK 293 cells were co-transfected with Atg14L-EGFP and Flag-Rubicon (e) or Rubicon-EGFP and Flag-Atg14L (f). Cell lysates were used for immunoprecipitation with an anti-GFP antibody and the resulting immunoprecipitates were blotted with an anti-Flag antibody. Our results show immunoprecipitation of Rubicon by Atg14L (e) and vice versa (f). WCL, whole cell lysate; IP, immunoprecipitated. See Supplementary Myc-Vps34-Vps15
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Degradation of long-lived proteins (normalized) PI(3)P fold change ) conditions (one-tailed Student's t-test with equal variances, n = 4). This difference was diminished when the starved cells were treated with 3-methyladenine (3MA, 10 mM), a PI(3)K inhibitor. (c) Vps34 kinase assay. HEK 293T cells were co-transfected with Myc-Vps34-Vps15 and Flag-Atg14L or Flag vector, either in the absence or in the presence of Beclin 1-EGFP. Myc-Vps34-Vps15 was immunoprecipitated by anti-Myc antibody for the in vitro kinase assay. The resulting radioactive PI(3)P was separated by thinlayer chromatography (TLC), quantified and normalized against the amount of immunoprecipitated Myc-tagged Vps34 as measured by western blot (upper panel). The quantified results (lower panel) show that overexpressing Atg14L significantly upregulated Vps34 kinase activity by 2.5-fold, but only when Beclin 1 was also overexpressed (*P = 0.04, one-tailed Student's t-test with unequal variances, n = 5). (d) Colocalization of co-expressed Atg14L-EGFP (green) and Beclin 1-AsRed (red) in punctate structures in transiently transfected HeLa cells. Scale bar, 10 μm. (e) Electron microscopy images show large structures (asterisks) that are often enwrapped with double membranes in the HEK 293T cells co-transfected with Atg14L-EGFP and Beclin 1-AsRed: concentric membrane 'rings' (panel 1); two large structures (3-5 μm in diameter, panel 2) containing material with high electron density (inset, enwrapping double membranes); numerous autophagosomes (arrows, panel 3) in the cytoplasm; immuno-electron microscopy image of a Atg14L-Beclin 1 structure (labelled with anti-GFP antibody and developed by DAB, panel 4) enwrapped with concentric membrane 'rings'. M, mitochondria; N, nucleus. Scale bar, 500 nm. (f, g) EGFP-Atg12 (f) or EGFP-Atg5 (g) (green) was colocalized with the large structures (arrows) that were labelled by Atg14L-AsRed (red) and Beclin 1-Myc (blue) in transfected HeLa cells. Some of these structures seemed to be 'ring'-shaped (yellow arrows and inset). Scale bar, 10 μm. See Supplementary  Information, Fig. S6 for full scans of blots in a and c. We then characterized the composition of the Beclin 1 complexes. Using anti-Atg14L and anti-Rubicon antibodies, we found that Atg14L co-immunoprecipitated with Vps34 ( Fig. S4a) and Beclin 1 (data not shown) but not with Rubicon ( Supplementary Information, Fig. S4a ). Rubicon co-immunoprecipitated with Vps34 and UVRAG, but not with Atg14L ( Supplementary Information, Fig. S4a ). Therefore, Atg14L and Rubicon seem to exist in separate Beclin 1 complexes.
We performed gel filtration experiments with tissue extracts prepared from either wild-type (Fig. 1d) or 'rescued' ( Supplementary  Information, Fig. S4b ) mouse liver. For each sample, eighty fractions of the eluent were collected and analysed by immunoblotting. We found that the endogenous Vps34, Beclin 1 (or Beclin 1-EGFP), Atg14L and Rubicon proteins were primarily co-eluted in fractions 38-45 ( Fig. 1d Supplementary Information, Fig. S4b ), suggesting that these fractions contain a major Beclin 1-Vps34 complex (>700K) that includes both Atg14L and Rubicon. We also performed gel filtration experiments with cell lysates prepared from stable cell lines expressing either Atg14L-EGFP ( Supplementary Information, Fig. S4c ) or Rubicon-EGFP ( Supplementary  Information, Fig. S4d ). Again, endogenous Beclin 1 was co-eluted with Atg14L-EGFP ( Supplementary Information, Fig. S4c ) and Rubicon-EGFP ( Supplementary Information, Fig. S4d) . Interestingly, starvation of these To test the possibility that Atg14L and Rubicon are present in separate protein complexes while co-eluted, we added an anti-Rubicon antibody to the tissue extract before the gel filtration run and immunoblotted the resulting fractions with an anti-Atg14L antibody. Our data show that Atg14L was co-eluted with the anti-Rubicon antibody ( Supplementary  Information, Fig. S4e ), indicating that this antibody binds to the Atg14L-containing complex, suggesting that Rubicon is present in this complex.
Moreover, we observed mutual co-immunoprecipitation of Atg14L and Rubicon from transfected cells, further supporting that Atg14L and Rubicon can be present in the same protein complex (Fig. 1e, f) ; UVRAG was also co-immunoprecipitated with Atg14L or Rubicon, and the interaction between UVRAG and Rubicon was significantly enhanced in the presence of Beclin 1 ( Supplementary Information, Fig. S4f-h) .
From these results, we conclude that Atg14L, Rubicon, UVRAG, Beclin 1, p150/Vps15 and Vps34 can form a major Beclin 1-Vps34 complex in vivo. However, Atg14L was also eluted in the later fractions (51-56) containing Beclin 1 or Beclin 1-EGFP (but not Rubicon; Fig. 1d ; Supplementary Information, Fig. S4b ), suggesting that Atg14L is also associated with a smaller Beclin 1 complex without Rubicon.
We performed several assays to determine the role of Atg14L in autophagy. First, we knocked down Atg14L expression in cultured cells by RNA interference (RNAi) using a short interfering RNA (siRNA) and analysed the levels of LC3II, a lipid-conjugated form of LC3 that is normally localized on autophagosomes, by immunoblotting [16] [17] [18] . As with Beclin 1 siRNA, Atg14L siRNA resulted in increased levels of LC3II, compared with control siRNA (Fig. 2a, left) . Second, we examined levels of p62/SQSTM1, a known autophagy substrate that normally accumulates when autophagy is impaired [19] [20] [21] . Again, like Beclin 1 siRNA, Atg14L siRNA resulted in increased p62/SQSTM1 levels (Fig. 2a) . The increase in p62/SQSTM1 and LC3II levels resulting from Beclin 1 or Atg14L siRNA treatment was also significant after starvation (Fig. 2a) . Therefore, knockdown of Atg14L or Beclin 1 impaired the autophagy-mediated clearance of p62/SQSTM1 and LC3II.
Third, we knocked down Atg14L expression in MLE12 cells that stably expressed GFP-LC3. In control siRNA-treated cells, many small GFP-LC3 puncta were observed, indicating that basal levels of autophagosomes were present ( Supplementary Information, Fig. S5a ). In contrast, Atg14L siRNA transfection resulted in accumulation of large GFP-LC3 puncta ( Supplementary Information, Fig. S5a ). These large GFP-LC3 puncta were colocalized with p62/SQSTM1 ( Supplementary  Information, Fig. S5b ) and ubiquitin ( Supplementary Information,  Fig. S5c ), indicating that these are ubiquitylated protein inclusions, as previously shown in Atg5-or Atg7-deficient mouse-tissues 22, 23 . Ultrastructural analysis showed that Atg14L siRNA transfection resulted in a reduced number of autophagosomes (data not shown). These analyses suggest that reduced Atg14L expression abolishes autophagosome formation and increases the levels of ubiquitylated proteins.
Fourth, under nutrient-rich conditions, Atg14L siRNA treatment caused a slight decrease in the rate of degradation of long-lived proteins (~10%, P = 0.007) when compared with control siRNA treatment. However, this rate was markedly reduced upon nutrient withdrawal (~37%, P = 5 × 10 -6 ) ; this effect of Atg14L siRNA was diminished in the presence of 3-methyladenine, an inhibitor of autophagy (Fig. 2b) .
Fifth, we investigated whether Atg14L modulates Vps34 kinase activity using a kinase assay that included Vps15/p150 (ref. 24 ). Our results show that co-expression of Flag-Atg14L with Myc-Vps34-Vps15 plasmids resulted in an increase in Vps34 activity that was 2.5-fold higher than that caused by co-expression of control Flag with Myc-Vps34-Vps15 plasmids (Fig. 2c) . Interestingly, Atg14L-mediated stimulation of Vps34 activity occurred only when co-expressing Beclin 1. This result suggests that overexpression of Atg14L enhances Vps34 activity in a Beclin 1-dependent manner.
Consistent with a previous report for Beclin 1-EGFP transgenic tissues 25 , we found that Atg14L-EGFP or Beclin 1-EGFP stably expressed in cells was primarily diffuse in the cytoplasm ( Supplementary Information,  Fig. S5d ). However, co-expression of Atg14L-EGFP and Beclin 1-AsRed resulted in their colocalization on punctate structures (Fig. 2d) . Electron microscopy analysis of these Atg14L-EGFP and Beclin 1-AsRed co-transfected cells showed many large 'organelles' (~3-5 μm; Fig. 2e ). Some of these structures show concentric 'rings' with double membranes (Fig. 2e1,  asterisks) ; many are large vacuole-like structures filled with materials of high electron density (Fig. 2e2, asterisks) and enwrapped with doublemembranes (Fig. 2e2, insets) that are readily distinguishable from typical aggresomes or protein aggregates (usually not associated with limiting membranes). These structures are positive for Atg14L-EGFP, as shown by immuno-electron microscopy ( Fig. 2e4) . We also observed an increased in the number of autophagosomes in these transfected cells (Fig. 2e3) .
We next studied the nature of these Beclin 1-Atg14L-resident structures. We found that these structures were negative for Golgi ( Supplementary  Information, Fig. S5e ) or ER ( Supplementary Information, Fig. S5f ) markers. In contrast, they were colocalized with GFP-LC3 ( Supplementary  Information, Fig. S5g ), suggesting that these Beclin 1-Atg14L structures probably recruit LC3. Moreover, they were colocalized with coexpressed EGFP-Atg12 (Fig. 2f) or EGFP-Atg5 (Fig. 2g) , suggesting that these Beclin 1-Atg14L structures may be involved in the early steps of autophagosome biosynthesis by recruiting Atg12 and Atg5.
To investigate the role of Rubicon in autophagy, we knocked down endogenous Rubicon protein levels. In contrast to Atg14L or Beclin 1 siRNA, Rubicon siRNA caused reduced steady-state levels of LC3II and p62/SQSTM under normal or nutrient-starvation conditions (Fig. 3a) , suggesting that knockdown of Rubicon promotes autophagic activity. Conversely, in cells stably or transiently transfected with Rubicon-EGFP, the p62/SQSTM1 protein levels were markedly enhanced, compared with those in cells transfected with EGFP (Fig. 3b) , suggesting that overexpression of Rubicon inhibits autophagy.
To examine whether Rubicon also modulates Vps34 lipid kinase activity, we performed the lipid kinase assay described above. Our results show that co-expression of Flag-Rubicon with Myc-Vps34-Vps15 markedly reduced Vps34 activity, but only in the absence of Beclin 1-EGFP overexpression (Fig. 3c) . This result suggests that overexpression of Rubicon inhibits Vps34 kinase activity and that this effect does not require Beclin 1.
In previous studies, mCherry-GFP-LC3 was used to examine autophagosome maturation, for example, autophagosome acidification following fusion with late endosomes/lysosomes 26 . We found that cells co-expressing mCherry-GFP-LC3 and Flag-Rubicon contained primarily yellow fluorescent mCherry-GFP-LC3 puncta (immature autophagosomes), whereas cells expressing only mCherry-GFP-LC3 or co-expressing mCherry-GFP-LC3 and control vector Flag contained considerable numbers of red fluorescent mCherry-GFP-LC3 puncta (mature autophagosomes; Fig. 3d, e) . This suggests that overexpression of Rubicon may block autophagy by inhibiting autophagosome maturation.
Interestingly, Rubicon-EGFP (or Flag-Rubicon, data not shown) expression showed punctate subcellular localization (Fig. 4a) . The Rubicon-EGFP puncta, some of which were 'ring'-shaped, were occasionally labelled with the early endosomal marker EEA1 ( Supplementary Information, Fig. S5h ) and were primarily colocalized with the late endosomal/lysosomal marker Lamp1 (Fig. 4a) . Moreover, some of the Rubicon-EGFP puncta were positively stained with an antibody against lysobisphosphatidic acid (LBPA; Fig. 4b ), an unusual eukaryotic lipid found only in the multi-vesicular body (MVB) 27 , suggesting that some of the Rubicon-EGFP structures may be related to the MVB 28 . Electron microscopy analysis of Rubicon-EGFP-transfected cells showed many abnormal, large, vacuole-like structures (1-5 μm in diameter; Fig. 4c ). Some of these structures contained high electron density molecules ( Fig. 4c1-2) , characteristic of late endosomes/lysosomes; some had relatively less content with overall low electron density, which may represent enlarged early-stage endosomes (Fig. 4c3) . Notably, some seemed to enclose numerous small vesicles of multiple layers (Fig. 4c2, 4) , whereas others resembled the MVB 28 ( Fig. 4c1-2) . Through immuno-electron microscopy using anti-GFP gold particles, we observed that these vacuole-like structures in the Rubicon-EGFP-transfected cells were positive for Rubicon-EGFP. Moreover, Rubicon-EGFP was associated with the limiting membranes of these particular structures (Fig. 4d3, 4) . Therefore, these structures corresponded to the fluorescent Rubicon-EGFP puncta (Fig. 4a) . In addition, our immuno-electron microscopy result confirmed the colocalization of Rubicon-EGFP and Lamp1 at the ultrastructural level (Fig. 4d5-7) .
Bioinformatic analysis revealed that the cysteine-rich domain of Rubicon shares sequence homology with the FYVE domain (Fig. 5a) , a well-characterized motif specific for phosphatidylinositol-3-phosphate (PI(3)P) binding 29 . When examined experimentally, Rubicon-EGFP was not pulled down by PI(3)P-conjugated sepharose beads, in contrast to the control PI(3)P-binding protein 2×FYVE-EGFP (data not shown). However, coexpressed Rubicon-AsRed and p40 (phox)-PX-EGFP, another reporter for PI(3)P binding, showed extensive colocalization (Fig. 5b) , suggesting that the Rubicon-associated structures are enriched in PI(3)P. Moreover, wortmanin, an inhibitor of Vps34 kinase, effectively dispersed the p40 (phox)-PX-EGFP puncta but not the Rubicon-AsRed structures (Fig. 5b) , suggesting that the maintenance of these Rubicon-associated structures does not depend on PI(3)P. Furthermore, through immunofluorescence imaging of Rubicon truncation mutants, we found that the cysteine-rich domain of Rubicon is required for the formation of the Rubicon-positive structures that are enriched in PI(3)P and associated with the aberrant endosomes/lysosomes (Fig. 5c) . Finally, we found that Beclin 1-AsRed or Flag-Beclin 1-CE was excluded from Rubicon-EGFP puncta (Fig. 5d, e) ; Beclin 1 siRNA did not affect the formation of the Rubicon-EGFP puncta (Fig. 5f) . Therefore, the formation of these Rubicon-associated, late endosomal/lysosomal structures are Beclin 1-independent.
In summary, our study has identified Atg14L and Rubicon, two components in the Beclin 1-Vps34 protein complexes, and reveals their distinct roles in regulating autophagy and Vps34 kinase activity. We show that Atg14L and Rubicon may regulate autophagy by modulating Vps34 activity. Our study also suggests the existence of multiple Beclin 1 protein complexes that are engaged in distinct functions in autophagy regulation (Fig. 5g) . The significance of these distinct Beclin 1 complexes remains to be fully elucidated. The dynamic change in protein composition between different functional Beclin 1-Vps34 complexes may have a central role in mediating the Beclin 1-Vps34 activity, which governs multiple cellular events, including autophagy. 
METHODS

Reagents, antibodies and microscopy. See Supplementary Information for details.
Mouse genetics. Becn1-EGFP/+ mice were generated using BAC mouse transgenics 30 .
Becn1-EGFP/+ transgenic and Becn1
+/-mice were genetically crossed to generate the 'rescued' mice in which both endogenous Becn1 alleles are deleted and only Becn1-EGFP transgene is expressed. See Supplementary Information for further details.
Affinity purification and mass spectrometry. Affinity purification of Beclin 1 interacting proteins and mass spectrometric identification of these proteins were carried out as described previously 19 with slight modifications. See Supplementary Information for details.
Plasmid constructs and stable cell lines. Total RNA was extracted from postnatal day 12 mouse whole brain using RNeasy mini kit (Qiagen). Full-length cDNA was synthesized with Omniscript RT kit (Qiagen) and used as templates for PCR amplifications with KOD HiFi DNA polymerase (Novagen) Vps34 kinase assay. Vps34 kinase assay was performed as described previously 31 . Myc-hVps34-hVps15-V5-His/pVITRO2 plasmid was transfected into HEK 293T cells in combination with other Flag-or EGFP-tagged plasmids. Cells were lysed in 1% Nonidet P-40 lysis buffer (20 mM Tris/pH 7.5, 137 mM NaCl, 1 mM MgC1 2 , 1 mM CaC1 2 , 100 mM NaF, 10 mM sodium pyrophosphate, 100 μM Na 3 VO 4 , 10% glycerol, 0.35 mg ml -1 PMSF, protease and phosphatase inhibitor cocktails). Immunoprecipitation was performed with anti-Myc affinity gel beads, according to the manufacturer's protocol (Sigma). Beads (associated with purified proteins) were washed three times in lysis buffer, followed by three washes in washing buffer (100 mM Tris-HCl/pH7.4 and 500 mM LiCl) and two washes in reaction buffer (10 mM Tri-HCl/pH7.4, 100 mM NaCl and 1 mM EDTA). Beads were resuspended in 60 μl of reaction buffer and MnCl 2 (10 μ1 of 100 mM) and sonicated phosphatidylinositol (10 μl of 2 μg μl -1 ) were added. The reaction was started by the addition of ATP (10 μl of 440 μM) containing γ-32 P-ATP (10 μCi), and beads were incubated for 10 min at room temperature. The reaction was terminated by adding HCl (20 μl of 8 M), and the organic phase was extracted with 160 μl chloroform:methanol (1:1). Extracted phospholipid products were resolved by TLC using a coated silica gel and a solvent composed of chloroform:methanol :H 2 O:ammonium hydroxide (v/v/v/v, 9:7:1.7:0.3), followed by visualization with Typhoon 9400 Variable Imager (GE Healthcare Biosciences).
Gel filtration. Liver and brain extracts from both Becn1
+/-and Becn1 -/-;Becn1-GFP/+ mice (4 months of age) were prepared as described in the Supplementary Information. Cell extracts were prepared as described previously 19 . Tissue and cell extracts were diluted with equal volumes of 2× pull-out buffer (1× containing 20 mM HEPES, pH 7.4, 1 mM MgCl 2 , PIC, 100 μg ml -1 PMSF, 2 μg ml -1 pepstatin, 0.2% triton X-100 and 150 mM NaCl) and incubated for 15 min at 4 °C. The samples were then subject to ultracentrifugation at 100,000g and the resulting supernatants were used for gel filtration experiments. A Superdex 200 HR10/30 column (Pharmacia) was equilibrated with 2-bed volumes of filtered running buffer (1× pull-out buffer without PIC and Triton-X-100). The column was calibrated using Biorad gel filtration calibrant mixtures that are composed of thyroglobulin (670K), γ-globulin (158K), ovalbumin (44K), myoglobin (17K) and vitamin B 12 (1, 350) . A spike of these calibrants (10 μl) was also added to each sample (240 μl) as internal calibrants. Both calibrants and samples were run at a flow rate of 0.2 ml min -1 . For each run, 2-bed volumes of running buffer were used to elute the sample and a total of 80 fractions were collected 25-29 min after starting the runs and at a rate of 1 fraction min -1 . Two bed volumes of running buffer were used to wash the column at the same flow rate in between two consecutive runs.
Long-lived protein degradation assay. Long-lived protein degradation was assessed as described previously 32 . In brief, NIH 3T3 cells were transfected with either control or Atg14L siRNA and plated in 12-well plates. After 48 h, DMEM was changed to leucine-free medium supplemented with 3 H-l-leucine (1 μCi ml -1 ). After being pulse-labelled for 24 h, cells were washed three times and cultured in DMEM supplemented with excess unlabelled leucine (5 mM) for 16 h to chase out short-lived proteins. Cells were then washed three times and further cultured for 4 h in DMEM, Earle's Balanced salt solution (EBSS), or EBSS supplemented with 10 mM 3-methyladenine, all containing unlabelled leucine (5 mM). Both medium and cell lysates were subject to trichloroacetic acid (TCA) precipitation. Long-lived protein degradation was calculated as the ratio of TCAsoluble medium to TCA-precipitated cell lysate radioactivity.
Statistical analysis. Statistical analyses were carried out as described previously 33 . 
Note: Supplementary Information is available on the Nature Cell Biology website.
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The authors declare no competing financial interests. (Fig. 1b) . The sequence coverage was 35.5%. (b) Mass spectrum of Rubicon identified from the gel band #2 (Fig. 1b) . Figure S4 Characterizing the Beclin 1 complexes. (a) Protein-protein interactions between endogenous UVRAG, Atg14L and Rubicon. Immunoprecipitation of endogenous Atg14L-and Rubicon-interacting proteins using anti-Atg14L and anti-Rubicon antibodies from NIH 3T3 cell lysate showed that Atg14L interacts with Vps34 and Rubicon interacts with Vps34 and UVRAG. The control experiments were preformed using the corresponding pre-immune sera. The whole cell lysates (WCL) and immunoprecipitated samples (IP) were examined by Western blot with antibodies against UVRAG, Vps34, Atg14L and Rubicon. (b) Western blot analysis of Atg14L, Rubicon, Vps34 and Beclin 1 in the gel filtration fractions from the "rescued" mice liver extract showed co-elution of these proteins in the same fractions 38-45. Atg14L was also eluted in later fractions 51-56. This result is consistent with the observation using wild-type mice (Fig. 1c) . The fractions for the peak elution of thyroglobulin (670 kDa) and γ-globulin was treated either without (upper panel) or with anti-Rubicon antibody (middle and lower panels) before loading onto the size exclusion column. Western blots using anti-Atg14L antibody showed ~65 kDa bands in the same fractions from both samples. In addition, three major anti-Rubicon antibody bands were also detected by the secondary anti-rabbit antibody (labeled by "*", "**" and "***"). The co-elution of Atg14L and anti-Rubicon antibody suggested that Atg14L and Rubicon were in the same Beclin 1-Vps34 complex. The fractions for the peak elution of thyroglobulin (670 kDa) and γ-globulin (158 kDa) are labeled by arrows. The lower panel is a film with long exposure for the sample incubated with anti-Rubicon antibody before loading onto the size exclusion column. The middle panel is short exposure for the same blot (lower panel) in order to reveal the unsaturated intensity of the strongest antibody band labeled by "*". (f) Protein-protein interaction between co-expressed UVRAG and Atg14L/Rubicon. HEK 293T cells were co-transfected with UVRAG-EGFP and control FLAG vector, FLAG-Atg14L or FLAG-Rubicon. Co-immunoprecipitation was performed with anti-GFP antibody, followed by detection with anti-FLAG antibody. The result showed that FLAG-Atg14L or FLAG-Rubicon was co-immunoprecipitated with UVRAG-EGFP. (g-h) Effect of Beclin 1 over-expression on protein-protein interactions between co-expressed UVRAG and Atg14L/Rubicon. UVRAG-EGFP was co-expressed with either FLAG-Atg14L (g) or FLAG-Rubicon (h) in HEK 293T cells, in the absence or in the presence of Beclin 1-myc. Coimmunoprecipitation was performed with anti-GFP antibody, followed by detection with anti-FLAG and anti-myc antibodies. The results showed that Beclin 1 over-expression markedly increased the amount of FLAG-Rubicon that was co-immunoprecipitated with UVRAG-EGFP (h) while having little effect on interaction between FLAG-Atg14L and UVRAG-EGFP (g). For (a, f-h), WCLwhole cell lysate, IP -immunoprecipitated. Beclin1-Myc GFP-LC3 Merge Figure S6 All whole gel images reported in this study. Figure S6 continued 
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Full scan for with EGFP expression were picked and cultured in medium supplemented with 200µg/ml G418.
Correct expression of EGFP-fusion protein was examined with western blot using GFP antibody.
Microscopy
For fluorescence microscopy, cultured cells were fixed in fresh 4% paraformaldehyde in 1×
PBS, and permeablized in PBS with either 0.05%-0.1% Triton X-100 or 0.01% saponin for 10-30 min at room temperature. After blocking in PBS containing 10% goat serum for 30 min-1 h at room temperature, cells were incubated in primary antibodies overnight at 4°C. After three washes in PBS, cells were incubated with fluorescent secondary antibodies for one hour at room temperature, followed by four washes in PBS. Cells were mounted with fluorescence mounting medium and examined under Zeiss (Göttingen, Germany) upright or invert confocal microscopes. sucrose. After three washes with 50 mM Tris/pH 7.4 supplemented with 7.5% sucrose, DAB
